366 related articles for article (PubMed ID: 15262415)
1. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.
Vila A; Gill H; McCallion O; Alonso MJ
J Control Release; 2004 Aug; 98(2):231-44. PubMed ID: 15262415
[TBL] [Abstract][Full Text] [Related]
2. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
3. [Transport of mPEG-PLGA nanoparticles across the rat nasal mucosa].
Wang JT; Lin DH; Qin LF; Wen Z; Guo GP
Yao Xue Xue Bao; 2013 May; 48(5):752-8. PubMed ID: 23888701
[TBL] [Abstract][Full Text] [Related]
4. PLA-PEG particles as nasal protein carriers: the influence of the particle size.
Vila A; Sánchez A; Evora C; Soriano I; McCallion O; Alonso MJ
Int J Pharm; 2005 Mar; 292(1-2):43-52. PubMed ID: 15725552
[TBL] [Abstract][Full Text] [Related]
5. PEG-PLA nanoparticles as carriers for nasal vaccine delivery.
Vila A; Sánchez A; Evora C; Soriano I; Vila Jato JL; Alonso MJ
J Aerosol Med; 2004; 17(2):174-85. PubMed ID: 15294069
[TBL] [Abstract][Full Text] [Related]
6. Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performance.
Stolnik S; Heald CR; Neal J; Garnett MC; Davis SS; Illum L; Purkis SC; Barlow RJ; Gellert PR
J Drug Target; 2001; 9(5):361-78. PubMed ID: 11770706
[TBL] [Abstract][Full Text] [Related]
7. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration.
Gao X; Tao W; Lu W; Zhang Q; Zhang Y; Jiang X; Fu S
Biomaterials; 2006 Jun; 27(18):3482-90. PubMed ID: 16510178
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers.
Gref R; Quellec P; Sanchez A; Calvo P; Dellacherie E; Alonso MJ
Eur J Pharm Biopharm; 2001 Mar; 51(2):111-8. PubMed ID: 11226817
[TBL] [Abstract][Full Text] [Related]
9. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration.
Tobío M; Gref R; Sánchez A; Langer R; Alonso MJ
Pharm Res; 1998 Feb; 15(2):270-5. PubMed ID: 9523314
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique.
Park SJ; Kim SH
J Colloid Interface Sci; 2004 Mar; 271(2):336-41. PubMed ID: 14972610
[TBL] [Abstract][Full Text] [Related]
12. Magnetic nanoparticles-loaded PLA/PEG microspheres as drug carriers.
Frounchi M; Shamshiri S
J Biomed Mater Res A; 2015 May; 103(5):1893-8. PubMed ID: 25203941
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
14. Polyethylenglycol-co-poly-D,L-lactide copolymer based microspheres: preparation, characterization and delivery of a model protein.
Dorati R; Genta I; Tomasi C; Modena T; Colonna C; Pavanetto F; Perugini P; Conti B
J Microencapsul; 2008 Aug; 25(5):330-8. PubMed ID: 18465305
[TBL] [Abstract][Full Text] [Related]
15. Intranasal delivery of zidovudine by PLA and PLA-PEG blend nanoparticles.
Mainardes RM; Khalil NM; Gremião MP
Int J Pharm; 2010 Aug; 395(1-2):266-71. PubMed ID: 20580792
[TBL] [Abstract][Full Text] [Related]
16. Preparation of uniform-sized PELA microspheres with high encapsulation efficiency of antigen by premix membrane emulsification.
Wei Q; Wei W; Tian R; Wang LY; Su ZG; Ma GH
J Colloid Interface Sci; 2008 Jul; 323(2):267-73. PubMed ID: 18501376
[TBL] [Abstract][Full Text] [Related]
17. Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles.
Essa S; Louhichi F; Raymond M; Hildgen P
J Microencapsul; 2013; 30(3):205-17. PubMed ID: 22894166
[TBL] [Abstract][Full Text] [Related]
18. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa.
De Campos AM; Sánchez A; Gref R; Calvo P; Alonso MJ
Eur J Pharm Sci; 2003 Sep; 20(1):73-81. PubMed ID: 13678795
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of microparticles made of carboxymethyloxysuccinic-acid-modified PLA-PEG co-polymer.
Zhang H; Chang L; Zhang B; Li P; Wang M; Yao KD; Yang J; Yao F
J Biomater Sci Polym Ed; 2008; 19(1):99-111. PubMed ID: 18177557
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
Sheshala R; Peh KK; Darwis Y
Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
